PENNY JOHNSON: Open Payments
NPI 1821186735 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 14 payments from 9 companies in 2025. Trend: 2023 $759 · 2024 $278 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $85 |
| Medtronic, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| PFIZER INC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: LEQVIO, VERQUVO, JARDIANCE, VYNDAQEL, AURORA EV-ICD MRI SURESCAN, Kerendia, REPATHA, CAMZYOS.
Industry payments across MD — which companies pay providers there.
